Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes

被引：0
|
作者：
Perez-Monteverde, A. [1 ]
Seck, T. [2 ]
Xu, L. [2 ]
Liu, G. [2 ]
Lee, M. A. [2 ]
Sisk, C. McCrary [2 ]
Williams-Herman, D. E. [2 ]
Kaufman, K. D. [2 ]
Goldstein, B. J. [2 ]
机构：
[1] Ctr Med Docente Trinidad, Caracas, Venezuela
[2] Merck Sharp & Dohme Corp, Rahway, NJ USA
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
820
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes
    Wainstein, J.
    Katz, L.
    Engel, S. S.
    Xu, L.
    Golm, G. T.
    Hussain, S.
    O'Neill, E. A.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (05): : 409 - 418
  • [22] EFFICACY AND SAFETY OF ADDING PIOGLITAZONE OR SITAGLIPTIN TO PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED WITH METFORMIN AND A SULFONYLUREA
    Liu, Sung-Chen
    Chien, Kuo-Liong
    Wang, Chao-Hung
    Chen, Wei-Che
    Leung, Ching-Hsiang
    ENDOCRINE PRACTICE, 2013, 19 (06) : 980 - 988
  • [23] Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naive Japanese patients with type 2 diabetes
    Ohta, Akio
    Ohshige, Toshihiko
    Sakai, Kensuke
    Nakamura, Yuta
    Tenjin, Ayumi
    Tsukiyama, Shuichi
    Terashima, Yuko
    Matsubara, Fumiaki
    Kawata, Takehiro
    Nagai, Yoshio
    Tanaka, Yasushi
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (17) : 2315 - 2322
  • [24] Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
    Scheen, Andre J.
    Charpentier, Guillaume
    Ostgren, Carl Johan
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (07) : 540 - 549
  • [25] Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial
    Guo, Li-xin
    Wang, Lian-wei
    Tian, De-zeng
    Xu, Feng-mei
    Huang, Wei
    Wu, Xiao-hong
    Zhu, Wei
    Chen, Jun-Qiu
    Zheng, Xin
    Zhou, Hai-Yan
    Li, Hong-Mei
    He, Zhong-Chen
    Wang, Wen-Bo
    Ma, Li-Zhen
    Duan, Jun-Ting
    DIABETES THERAPY, 2024, 15 (11) : 2351 - 2366
  • [26] Effects of a fixed-dose combination of sitagliptin and metformin versus respective monotherapies in newly diagnosed type 2 diabetic subjects
    Deepak S. Bhosle
    Abhijeet H. Bhagat
    Anant D. Patil
    Jyoti A. Bobde
    Amrapali A. Bhagat
    International Journal of Diabetes in Developing Countries, 2017, 37 : 16 - 20
  • [27] Effects of a fixed-dose combination of sitagliptin and metformin versus respective monotherapies in newly diagnosed type 2 diabetic subjects
    Bhosle, Deepak S.
    Bhagat, Abhijeet H.
    Patil, Anant D.
    Bobde, Jyoti A.
    Bhagat, Amrapali A.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (01) : 16 - 20
  • [28] Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    Comaschi, M.
    Demlcheli, A.
    Di Pietro, C.
    Bellatreccia, A.
    Mariz, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (04) : 387 - 398
  • [29] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    DIABETOLOGIA, 2015, 58 : S54 - S54
  • [30] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
12345